Reports On Defective Medical Devices In Heifei City Increase By 20 Times In One Year
This article was originally published in PharmAsia News
Executive Summary
The Heifei City FDA recently announced progress in its monitoring reports on defective medical devices. The city received a total of 454 reports in 2008, which was 20 times more than in 2007. Among these reports, 72 concerned third-category medical devices, and covered 21 types of medical devices. The reports were filed by 78 manufacturing companies and medical institutions. The city's FDA will further expand its supervision by advocating the proper use of medical devices and focusing on third-category medical devices. (Click here for more
You may also be interested in...
Japan Grants Global-First Approval To Zolbetuximab, 15 Other New Drugs
Astellas's first-in class CLDN18.2-targeting antibody receives its first approval worldwide, while crovalimab and a number of drugs for rare diseases also receive nods from regulators and are now awaiting reimbursement price-listing.
Hanmi-OCI Merger Hits Wall As Brothers Win Shareholder Vote, Board Seats
The planned merger of Korea's Hanmi Pharm Group with OCI Group hits a major speed bump as the two sons of Hanmi's founder and other candidates recommended by them secture board seats. But it remains to be seen how the Lim brothers will fulfil their ambitious promises.
Beauty Firms Using AI-Based Tools Could Be Subject To Health Privacy Laws In US States
Using AI-based programs to collect and store consumer information risks running afoul of new health privacy laws cropping up in US states. Lack of federal regulation or guidance on the issue is one of the biggest challenges for beauty firms deploying AI, according to Stacy Marcus, partner at Reed Smith LLP.